UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 810

Sortiert nach

Sofosbuvir/velpatasvir and glecaprevir/pibrentasvir: how should we choose among these two latest and probably the last regimens?

Hepatology research, 2022-10, Vol.52 (10), p.815-816

Toyoda, Hidenori

2022

Link zum Volltext

Verfügbarkeit prüfen

Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning

Modern pathology, 2021-02, Vol.34 (2), p.417-425

2021

Link zum Volltext

Verfügbarkeit prüfen

Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1

PloS one, 2023-02, Vol.18 (2), p.e0278143-e0278143

2023

Link zum Volltext

Verfügbarkeit prüfen

Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts

Journal of gastroenterology, 2022-04, Vol.57 (4), p.309-321

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

Journal of hepatology, 2018-12, Vol.69 (6), p.1284-1293

2018

Link zum Volltext

Verfügbarkeit prüfen

The best predictive model for post-SVR HCC: can it be universal?

Hepatology international, 2022-06, Vol.16 (3), p.728-728

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis

Hepatology research, 2019-01, Vol.49 (1), p.111-117

2019

Link zum Volltext

Verfügbarkeit prüfen

Changes in patient backgrounds may increase the incidence of HCC after SVR in the era of IFN‐free therapy for HCV

Hepatology (Baltimore, Md.), 2016-11, Vol.64 (5), p.1818-1819

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

Journal of gastroenterology, 2020-09, Vol.55 (9), p.899-908

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Liver cancer (Basel ), 2021-06, Vol.10 (3), p.181-223

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis

Journal of gastroenterology, 2016-07, Vol.51 (7), p.741-747

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

The lancet. Gastroenterology & hepatology, 2019-05, Vol.4 (5), p.389-398

2019

Link zum Volltext

Verfügbarkeit prüfen

Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

Journal of gastroenterology, 2020-06, Vol.55 (6), p.653-661

2020

Link zum Volltext

Verfügbarkeit prüfen

Differences in the impact of prognostic factors for hepatocellular carcinoma over time

Cancer science, 2017-12, Vol.108 (12), p.2438-2444

2017

Link zum Volltext

Verfügbarkeit prüfen

Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI

American journal of roentgenology (1976), 2011-07, Vol.197 (1), p.58

2011

Link zum Volltext

Verfügbarkeit prüfen

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

Journal of gastroenterology, 2017-04, Vol.52 (4), p.520-533

2017

Link zum Volltext

Verfügbarkeit prüfen

Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population

Hepatology research, 2022-01, Vol.52 (1), p.81-92

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Clinical gastroenterology and hepatology, 2016-06, Vol.14 (6), p.875-886.e6

2016

Link zum Volltext

Verfügbarkeit prüfen

Long‐term persistence of hepatocarcinogenic potential of a non‐hypervascular hypointense nodule on EOB‐MRI after the eradication of hepatitis C virus

Hepatology research, 2022-01, Vol.52 (1), p.128-132

2022

Link zum Volltext

Verfügbarkeit prüfen

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

The Lancet infectious diseases, 2015-06, Vol.15 (6), p.645-653

2015

Link zum Volltext

Verfügbarkeit prüfen

Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development

Pathology international, 2010-05, Vol.60 (5), p.351-357

2010

Link zum Volltext

Verfügbarkeit prüfen

The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families

PloS one, 2011-01, Vol.6 (1), p.e16081-e16081

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus core‐related antigen levels predict progression to liver cirrhosis in hepatitis B carriers

Journal of gastroenterology and hepatology, 2018-04, Vol.33 (4), p.918-925

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

Journal of gastroenterology, 2018-04, Vol.53 (4), p.566-575

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 810

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(758)
Mit Volltextzugriff
(734)

Publikationsform

Artikel
(808)
Berichte
(2)

Sprache

Englisch
(742)
Japanisch
(236)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology Research
(53)
Journal Of Gastroenterology And Hepatology
(52)
Journal Of Hepatology
(46)
Kanzo
(35)
Journal Of Gastroenterology
(34)
Journal Of Medical Virology
(22)
Liver International
(21)
Hepatology International
(20)
Plos One
(20)
Clinical Gastroenterology And Hepatology
(16)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(9)
... seit 90 Tagen
(26)

Menü

Weitere Dienste

Einstellungen

Sofosbuvir/velpatasvir and glecaprevir/pibrentasvir: how should we choose among these two latest and probably the last regimens?

Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning

Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1

Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

The best predictive model for post-SVR HCC: can it be universal?

Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis

Changes in patient backgrounds may increase the incidence of HCC after SVR in the era of IFN‐free therapy for HCV

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

Differences in the impact of prognostic factors for hepatocellular carcinoma over time

Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Long‐term persistence of hepatocarcinogenic potential of a non‐hypervascular hypointense nodule on EOB‐MRI after the eradication of hepatitis C virus

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development

The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

Hepatitis B virus core‐related antigen levels predict progression to liver cirrhosis in hepatitis B carriers

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

Suchergebnisse filtern